SCHEDULE: Sabby Entities Disclose 9.9% Stake in Oragenics Inc.

Sabby Management, Hal Mintz, and Sabby Volatility Warrant Master Fund, Ltd. have disclosed a combined 9.9% beneficial ownership in Oragenics Inc. common stock.

Summary

• Sabby Management, LLC, Hal Mintz, and Sabby Volatility Warrant Master Fund, Ltd. collectively reported beneficial ownership of 412,654 shares of Oragenics Inc. common stock.
• This ownership represents 9.9% of Oragenics Inc.'s outstanding common stock.
• The reporting persons share both voting and dispositive power over all 412,654 shares.
• The securities were not acquired or held for the purpose of changing or influencing control of Oragenics Inc., except for activities solely in connection with a nomination under Rule 240.14a-11.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership, which is neutral in sentiment. The presence of a significant institutional holder could be seen as a minor positive, but the filing itself contains no performance or forward-looking statements to sway sentiment significantly.

Positives

• Disclosure of a significant 9.9% stake by institutional investors (Sabby Management and its affiliates) may signal increased institutional interest in Oragenics Inc.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of beneficial ownership by an institutional investor, indicating a significant stake in a publicly traded company. It does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, which can influence market perception and potentially share price.

Key Dates

Keywords

Oragenics Inc., Sabby Management, Hal Mintz, Sabby Volatility Warrant Master Fund, Beneficial Ownership, Common Stock, SEC Filing, Schedule 13G, Institutional Investor